BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17938247)

  • 1. Splicing- and cleavage-independent requirement of RNA polymerase II CTD for mRNA release from the transcription site.
    Custódio N; Vivo M; Antoniou M; Carmo-Fonseca M
    J Cell Biol; 2007 Oct; 179(2):199-207. PubMed ID: 17938247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3' end processing.
    Fong N; Bird G; Vigneron M; Bentley DL
    EMBO J; 2003 Aug; 22(16):4274-82. PubMed ID: 12912924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo.
    Gu B; Eick D; Bensaude O
    Nucleic Acids Res; 2013 Feb; 41(3):1591-603. PubMed ID: 23275552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.
    Fong N; Bentley DL
    Genes Dev; 2001 Jul; 15(14):1783-95. PubMed ID: 11459828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two steps of poly(A)-dependent termination, pausing and release, can be uncoupled by truncation of the RNA polymerase II carboxyl-terminal repeat domain.
    Park NJ; Tsao DC; Martinson HG
    Mol Cell Biol; 2004 May; 24(10):4092-103. PubMed ID: 15121832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase.
    Natalizio BJ; Robson-Dixon ND; Garcia-Blanco MA
    J Biol Chem; 2009 Mar; 284(13):8692-702. PubMed ID: 19176527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription.
    McCracken S; Fong N; Yankulov K; Ballantyne S; Pan G; Greenblatt J; Patterson SD; Wickens M; Bentley DL
    Nature; 1997 Jan; 385(6614):357-61. PubMed ID: 9002523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordination of RNA Polymerase II Pausing and 3' End Processing Factor Recruitment with Alternative Polyadenylation.
    Fusby B; Kim S; Erickson B; Kim H; Peterson ML; Bentley DL
    Mol Cell Biol; 2016 Jan; 36(2):295-303. PubMed ID: 26527620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.
    Rosonina E; Blencowe BJ
    RNA; 2004 Apr; 10(4):581-9. PubMed ID: 15037767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo.
    Rosonina E; Ip JY; Calarco JA; Bakowski MA; Emili A; McCracken S; Tucker P; Ingles CJ; Blencowe BJ
    Mol Cell Biol; 2005 Aug; 25(15):6734-46. PubMed ID: 16024807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements of the RNA polymerase II C-terminal domain for reconstituting pre-mRNA 3' cleavage.
    Ryan K; Murthy KG; Kaneko S; Manley JL
    Mol Cell Biol; 2002 Mar; 22(6):1684-92. PubMed ID: 11865048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export.
    Yoh SM; Cho H; Pickle L; Evans RM; Jones KA
    Genes Dev; 2007 Jan; 21(2):160-74. PubMed ID: 17234882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A link between nuclear RNA surveillance, the human exosome and RNA polymerase II transcriptional termination.
    de Almeida SF; García-Sacristán A; Custódio N; Carmo-Fonseca M
    Nucleic Acids Res; 2010 Dec; 38(22):8015-26. PubMed ID: 20699273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo.
    Misteli T; Spector DL
    Mol Cell; 1999 Jun; 3(6):697-705. PubMed ID: 10394358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.
    Xiang K; Nagaike T; Xiang S; Kilic T; Beh MM; Manley JL; Tong L
    Nature; 2010 Oct; 467(7316):729-33. PubMed ID: 20861839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozyme cleavage reveals connections between mRNA release from the site of transcription and pre-mRNA processing.
    Bird G; Fong N; Gatlin JC; Farabaugh S; Bentley DL
    Mol Cell; 2005 Dec; 20(5):747-58. PubMed ID: 16337598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.
    Emili A; Shales M; McCracken S; Xie W; Tucker PW; Kobayashi R; Blencowe BJ; Ingles CJ
    RNA; 2002 Sep; 8(9):1102-11. PubMed ID: 12358429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.
    Zeng C; Berget SM
    Mol Cell Biol; 2000 Nov; 20(21):8290-301. PubMed ID: 11027297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key features of the interaction between Pcf11 CID and RNA polymerase II CTD.
    Noble CG; Hollingworth D; Martin SR; Ennis-Adeniran V; Smerdon SJ; Kelly G; Taylor IA; Ramos A
    Nat Struct Mol Biol; 2005 Feb; 12(2):144-51. PubMed ID: 15665873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II.
    Kim M; Krogan NJ; Vasiljeva L; Rando OJ; Nedea E; Greenblatt JF; Buratowski S
    Nature; 2004 Nov; 432(7016):517-22. PubMed ID: 15565157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.